There is a need to have detailed information that directs adequate healthcare, which requires the implementation of available measures for detailed screening of the elderly, with the use of validated instruments such as the MMSE, the use of biomarkers such as hemoglobin, urea, creatinine, calcium, phosphorus, albumin, C-reactive protein (CRP), HbA1c, and fibrinogen, which direct the identification of sarcopenia and the identification of falls for a diagnostic, safe, and evidence-based practice [8]. This evidence concerns the gene CRP and sarcopenia.